Raymond James & Associates’s Strata Critical Medical, Inc. Class A Common Stock SRTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $1.3M | Sell |
440,635
-213,252
| -33% | -$627K | ﹤0.01% | 2507 |
|
|
2024
Q2 | $2.28M | Buy |
653,887
+37,243
| +6% | +$130K | ﹤0.01% | 2075 |
|
|
2024
Q1 | $1.76M | Buy |
616,644
+362,784
| +143% | +$1.03M | ﹤0.01% | 2243 |
|
|
2023
Q4 | $896K | Sell |
253,860
-221,232
| -47% | -$781K | ﹤0.01% | 2575 |
|
|
2023
Q3 | $1.23M | Buy |
+475,092
| New | +$1.23M | ﹤0.01% | 2316 |
|
|
2022
Q1 | – | Sell |
-49,740
| Closed | -$439K | – | 3945 |
|
|
2021
Q4 | $439K | Sell |
49,740
-19,241
| -28% | -$170K | ﹤0.01% | 3168 |
|
|
2021
Q3 | $717K | Buy |
68,981
+706
| +1% | +$7.34K | ﹤0.01% | 2794 |
|
|
2021
Q2 | $717K | Buy |
68,275
+2,425
| +4% | +$25.5K | ﹤0.01% | 2813 |
|
|
2021
Q1 | $678K | Buy |
65,850
+41,250
| +168% | +$425K | ﹤0.01% | 2772 |
|
|
2020
Q4 | $273K | Buy |
+24,600
| New | +$273K | ﹤0.01% | 3154 |
|